España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Puma Biotechnology
PBYI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.98
0.01000
0.34%
At close: -
$2.98
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Puma Biotechnology (PBYI) Forecast
News
Earnings
Puma Biotechnology (PBYI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Puma Biotechnology (NASDAQ:PBYI) Stock
Puma Biotechnology Stock (NASDAQ: PBYI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 23, 2024
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Puma Biotechnology's NERLYNX Added To NCCN Gu...
Benzinga Newsdesk
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Puma Biotechnology Initiates ALISCAâ„¢-Breast1 ...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Puma Biotechnology shares are trading higher ...
Benzinga Newsdesk
Thursday, November 07, 2024
Puma Biotechnology expects Q424 Net Product R...
Benzinga Newsdesk
Puma Biotechnology Q3 2024 Adj. EPS $0.45 Bea...
Benzinga Newsdesk
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, August 02, 2024
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Thursday, August 01, 2024
Puma Biotechnology Sees Q3 Revenue $50M-$53M ...
Benzinga Newsdesk
Puma Biotechnology Q2 2024 Adj. EPS $(0.05) B...
Benzinga Newsdesk
Friday, July 26, 2024
Where Puma Biotechnology Stands With Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Tuesday, June 04, 2024
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Monday, June 03, 2024
Puma Biotechnology Presents Phase I/Ib Study ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Sunday, June 02, 2024
Puma Biotechnology Announced Presentation of Findings From Phase II Study Of Alisertib In Endocrine-Resistant Metastatic Breast Cancer ASCO 2024
Charles Gross
Tuesday, May 28, 2024
Puma Biotechnology To Join Russell 3000 Index
Benzinga Newsdesk
Monday, May 20, 2024
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Friday, May 17, 2024
Puma Biotechnology Says Jury Verdict Was Ente...
Benzinga Newsdesk
Friday, May 03, 2024
Puma Biotechnology's Q1 Earnings and Revenues Beat
Zacks
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Thursday, May 02, 2024
Puma Biotechnology Sees Q2 Net Product Revenu...
Benzinga Newsdesk
Puma Biotechnology Q1 2024 Adj EPS $(0.05) Be...
Benzinga Newsdesk
Wednesday, March 20, 2024
Puma Biotechnology Announces FDA Allowance To...
Benzinga Newsdesk
Tuesday, March 19, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, March 18, 2024
Watching Puma Biotechnology; Traders Circulat...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Maintains Buy on Puma Bio...
Benzinga Newsdesk
Thursday, February 29, 2024
Puma Biotechnology Sees FY24 Net Product Reve...
Benzinga Newsdesk
Puma Biotechnology Sees Q1 2024 Net Product R...
Benzinga Newsdesk
Puma Biotechnology shares are trading lower a...
Benzinga Newsdesk
Puma Biotechnology Q4 2023 Adj EPS $0.310 Bea...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, February 13, 2024
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Puma Biotechnology Initiates ALISCA-Lung1 Pha...
Benzinga Newsdesk
Monday, December 11, 2023
Puma Biotechnology Announces Phase II Clinica...
Benzinga Newsdesk
Friday, November 10, 2023
Puma Biotechnology Board Member Trades Company's Stock
Benzinga Insights
Thursday, November 02, 2023
Puma Biotechnology Sees FY23 Revenue $206M-$2...
Benzinga Newsdesk
Puma Biotechnology Sees Q4 2023 Product Reven...
Benzinga Newsdesk
Puma Biotechnology Q3 2023 Adj EPS $0.17 Beat...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Monday, October 16, 2023
Puma Biotechnology Presented Findings From A ...
Benzinga Newsdesk
Thursday, September 21, 2023
Puma Biotechnology Secures FDA Orphan Drug De...
Benzinga Newsdesk
Wednesday, September 20, 2023
HC Wainwright & Co. Reiterates Buy on Puma Bi...
Benzinga Newsdesk
Tuesday, August 08, 2023
Puma Biotechnology Announces FDA Clearance Of...
Benzinga Newsdesk
Friday, August 04, 2023
Puma Biotechnology shares are trading higher ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
